Form 4: Procept BioRobotics Director Mary Garrett Reports Stock Option Grant and RSU Vesting

Director Mary Garrett reported the acquisition of stock options and vesting of restricted stock units (RSUs) in Procept BioRobotics Corp.

Summary

• On June 4, 2024, Mary Garrett, a director of Procept BioRobotics Corp, reported transactions involving the company's stock.
• Garrett acquired 2,526 stock options with an exercise price of $67.29.
• These options vest fully on the earlier of the one-year anniversary of the grant date (June 4, 2025) or the date of the next annual meeting following the grant date, contingent upon continued service.
• Additionally, 1,376 restricted stock units (RSUs) vested, each representing a contingent right to receive one share of common stock.
• These RSUs vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service.
• Following these transactions, Garrett directly owns 2,526 derivative securities and 12,847 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants and RSU vesting, which is a common practice for incentivizing company directors. There's no indication of unusual or concerning activity.

Positives

• The grant of stock options and vesting of RSUs align the director's interests with those of the shareholders.
• The vesting schedule is tied to continued service, incentivizing the director to remain with the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, in their company's stock. This allows investors to monitor insider activity, which can provide insights into management's perspective on the company's performance and future prospects.

Stakeholder Impact

• The transactions reported in the Form 4 filing provide transparency to shareholders regarding the compensation and equity ownership of a company director.

Key Dates